Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03595384 · ClinicalTrials.gov registry record · NA
Soccer-based Adaptation of the Diabetes Prevention Program
A NA study, sponsored by Emory University.
- Completed
- Registry status
- NA
- Development phase
- 41
- Enrollment target
NCT03595384 is a NA study that has completed, run by Emory University. The registered enrollment target is 41 participants.
The verdict
NCT03595384, a NA study, has completed, sponsored by Emory University.
- COMPLETED
- Registry status
- NA
- Development phase
- 41 participants
- Enrollment target
Study Summary
This is a longitudinal pre-post pilot intervention study evaluating feasibility of implementation of a soccer-based Diabetes Prevention Program (DPP) and preliminary changes in physical activity and diet-related measures. Overweight participants at high risk for type 2 diabetes mellitus (T2DM) will be recruited through soccer interest groups, local leagues and Hispanic health organizations. After a baseline assessment visit, participants will attend soccer practice twice a week for 12 weeks while completing the National Diabetes Prevention Program (NDPP) core curriculum online modules with facilitated discussion by trained coaches during each soccer practice. Participants will then be invited to join an established small-sided soccer league in their community (for 12 weeks) offering one game per week and will also complete the NDPP maintenance modules and physical activity and diet self-tracking via mobile health technologies. After the core (first 12 weeks) and maintenance intervention periods (second 12 weeks) baseline measurements will be repeated. Data on the feasibility of this DPP soccer-based adaptation will inform future randomized, controlled trials testing the effectiveness of this translation model to reduce T2DM risk while extrapolating to other sports-based adaptation and age, gender and racial sub-populations.
Interventions
- BEHAVIORAL Soccer-based adaptation to the DPP
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 41 participants |
| Start Date | 2018-04-29 |
| Est. Completion | 2018-12-16 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03595384
The ClinicalTrials.gov registry entry for NCT03595384 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 41 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Emory University, which has 1,208 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Soccer-based adaptation to the DPP is the first listed.
NCT03595384 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03595384 about?
NCT03595384 is a clinical study titled "Soccer-based Adaptation of the Diabetes Prevention Program". This is a longitudinal pre-post pilot intervention study evaluating feasibility of implementation of a soccer-based Diabetes Prevention Program (DPP) and preliminary changes in physical activity and diet-related measures. Overweight participants at high risk for type 2 diabetes mellitus (T2DM) will ...
What is the current status of trial NCT03595384?
This trial is currently completed. It is a NA study. The enrollment target is 41 participants. The study started on 2018-04-29. Estimated completion is 2018-12-16.
What interventions are being tested in trial NCT03595384?
The interventions under investigation include: Soccer-based adaptation to the DPP (BEHAVIORAL).
Who is sponsoring clinical trial NCT03595384?
This trial is sponsored by Emory University, which has 1,208 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.